Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günter Emons

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Exposure of mcf-7 breast cancer cells to electromagnetic fields up-regulates the plasminogen activator systemRainer Girgert, Günter Emons, Volker Hanf, et al.
The Journal of Obstetrics and Gynaecology Research|April 25, 2019
Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cellsCarsten Gründker, Ulrike Wokoun, Martin Hellriegel, et al.
Journal of Pineal Research|June 16, 2009
Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cellsRainer Girgert, Volker Hanf, Günter Emons, et al.
Bioelectromagnetics|November 22, 2007
Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cellsRainer Girgert, Carsten Gründker, Günter Emons, et al.
International Journal of Oncology|November 26, 2014
Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cellsOliver Hinsche, Rainer Girgert, Günter Emons, et al.
Journal of Perinatal Medicine|August 1, 2012
The impact of the time interval between two successive deliveries in an obstetric unit in terms of the mode of each delivery and the rate of perinatal mortalityWerner Stein, Thomas Hawighorst, Paul Wenzlaff, et al.
Breast Cancer Research and Treatment|February 1, 2011
Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivoAntje Schubert, Thomas Hawighorst, Günter Emons, et al.
Oncology Reports|March 29, 2017
Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumorsUlrike Wokoun, Martin Hellriegel, Günter Emons, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 28, 2008
Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expressionAntje Schubert, Hiltrud Schulz, Günter Emons, et al.
International Journal of Oncology|April 22, 2016
Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRHCarsten Gründker, Gerd Bauerschmitz, Antje Schubert, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Exposure of mcf-7 breast cancer cells to electromagnetic fields up-regulates the plasminogen activator systemRainer Girgert, Günter Emons, Volker Hanf, et al.
The Journal of Obstetrics and Gynaecology Research|April 25, 2019
Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cellsCarsten Gründker, Ulrike Wokoun, Martin Hellriegel, et al.
Journal of Pineal Research|June 16, 2009
Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cellsRainer Girgert, Volker Hanf, Günter Emons, et al.
Bioelectromagnetics|November 22, 2007
Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cellsRainer Girgert, Carsten Gründker, Günter Emons, et al.
International Journal of Oncology|November 26, 2014
Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cellsOliver Hinsche, Rainer Girgert, Günter Emons, et al.
Journal of Perinatal Medicine|August 1, 2012
The impact of the time interval between two successive deliveries in an obstetric unit in terms of the mode of each delivery and the rate of perinatal mortalityWerner Stein, Thomas Hawighorst, Paul Wenzlaff, et al.
Breast Cancer Research and Treatment|February 1, 2011
Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivoAntje Schubert, Thomas Hawighorst, Günter Emons, et al.
Oncology Reports|March 29, 2017
Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumorsUlrike Wokoun, Martin Hellriegel, Günter Emons, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 28, 2008
Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expressionAntje Schubert, Hiltrud Schulz, Günter Emons, et al.
International Journal of Oncology|April 22, 2016
Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRHCarsten Gründker, Gerd Bauerschmitz, Antje Schubert, et al.
Pageof 12